Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Ultraviolet Ventures
- 11/11/2022
- Seed
- $2,300,000
Ultraviolet is rethinking traditional angel investing. We’re a syndicate of founders, creators and community builders, bound by a shared desire to amplify daring startups.
- Industry Venture Capital and Private Equity Principals
- Website https://ultraviolet.ventures/
- LinkedIn https://www.linkedin.com/company/ultravioletvc/
Related People
Max MarchioneFounder
United States -
San Francisco, California
maxmarchione.com
Hi! I'm Max. I write about how I see the world, including human behaviour, healthcare, startup strategy, productivity, venture investing, and brand-building.
Things that interest me:
Longevity, large language models, metabolomics, genomics, philosophical debates, probability in real life, health optimisation (first wore a CGM at age 16, tracked sleep with EEG, ran models on my data), architecture, design, food, skiing, neuroscience, great speeches.
Background:
Worked in venture-backed startups, in VC, and did a short stint Goldman Sachs. Ranked 1 at the country’s top law school before dropping out to study maths/stats/AI instead and build two small companies on the side - Ultraviolet and Next Chapter (6,000 subs in 6 months).
What's keeping me busy:
- Rethinking angel investing 👉 Ultraviolet Ventures
- Remaking social clubs👉 Next Chapter
- Something new
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)